[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.14348/molcells.2015.0103

Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9

Koo, Taeyoung (Center for Genome Engineering, Institute for Basic Science)
Lee, Jungjoon (The Institute of Molecular Biology and Genetics)
Kim, Jin-Soo (Center for Genome Engineering, Institute for Basic Science)

Publication Information

Abstract

Programmable nucleases, which include zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and RNA-guided engineered nucleases (RGENs) repurposed from the type II clustered, regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system are now widely used for genome editing in higher eukaryotic cells and whole organisms, revolutionising almost every discipline in biological research, medicine, and biotechnology. All of these nucleases, however, induce off-target mutations at sites homologous in sequence with on-target sites, limiting their utility in many applications including gene or cell therapy. In this review, we compare methods for detecting nuclease off-target mutations. We also review methods for profiling genome-wide off-target effects and discuss how to reduce or avoid off-target mutations.

Keywords

Cas9; CRISPR; genome editing; off-target; TALEN; ZFN;

Citations & Related Records

Reference

1	Kuscu, C., Arslan, S., Singh, R., Thorpe, J., and Adli, M. (2014). Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol. 32, 677-683. DOI ScienceOn
2	Lee, H.J., Kim, E., and Kim, J.S. (2010). Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res. 20, 81-89. DOI ScienceOn
3	Lee, H.J., Kweon, J., Kim, E., Kim, S. and Kim, J.S. (2012) .Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res. 22, 539-548. DOI ScienceOn
4	Lin, Y., Cradick, T.J., Brown, M.T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B.M., Vertino, P.M., Stewart, F.J. and Bao, G. (2014). CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 42, 7473-7485. DOI ScienceOn
5	Mali, P., Aach, J., Stranges, P.B., Esvelt, K.M., Moosburner, M., Kosuri, S., Yang, L. and Church, G.M. (2013a). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833-838. DOI ScienceOn
6	Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., and Church, G.M. (2013b). RNA-guided human genome engineering via Cas9. Science 339, 823-826. DOI
7	Miller, J.C., Tan, S., Qiao, G., Barlow, K.A., Wang, J., Xia, D.F., Meng, X., Paschon, D.E., Leung, E., Hinkley, S.J., et al. (2011). A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29, 143-148. DOI ScienceOn
8	Moscou, M.J., and Bogdanove, A.J. (2009). A simple cipher governs DNA recognition by TAL effectors. Science 326, 1501. DOI ScienceOn
9	Mussolino, C., Morbitzer, R., Lutge, F., Dannemann, N., Lahaye, T. and Cathomen, T. (2011). A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res. 39, 9283-9293. DOI ScienceOn
10	Parant, J.M., George, S.A., Pryor, R., Wittwer, C.T., and Yost, H.J. (2009). A rapid and efficient method of genotyping zebrafish mutants. Dev. Dyn. 238, 3168-3174. DOI ScienceOn
11	Park, C.Y., Kim, J., Kweon, J., Son, J.S., Lee, J.S., Yoo, J.E., Cho, S.R., Kim, J.H., Kim, J.S., and Kim, D.W. (2014). Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs. Proc. Natl. Acad. Sci. USA 111, 9253-9258. DOI ScienceOn
12	Pattanayak, V., Ramirez, C.L., Joung, J.K., and Liu, D.R. (2011). Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods 8, 765-770. DOI ScienceOn
13	Pattanayak, V., Lin, S., Guilinger, J.P., Ma, E., Doudna, J.A., and Liu, D.R. (2013). High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839-843. DOI ScienceOn
14	Ramakrishna, S., Kwaku Dad, A.B., Beloor, J., Gopalappa, R., Lee, S.K., and Kim, H. (2014). Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res. 24, 1020-1027. DOI ScienceOn
15	Ran, F.A., Hsu, P.D., Lin, C.Y., Gootenberg, J.S., Konermann, S., Trevino, A.E., Scott, D.A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380-1389. DOI ScienceOn
16	Zuris, J.A., Thompson, D.B., Shu, Y., Guilinger, J.P., Bessen, J.L., Hu, J.H., Maeder, M.L., Joung, J.K., Chen, Z.Y. and Liu, D.R. (2015). Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73-80. DOI
17	Wu, X., Scott, D.A., Kriz, A.J., Chiu, A.C., Hsu, P.D., Dadon, D.B., Cheng, A.W., Trevino, A.E., Konermann, S., Chen, S., et al. (2014). Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32, 670-676. DOI ScienceOn
18	Yusa, K., Rashid, S.T., Strick-Marchand, H., Varela, I., Liu, P.Q., Paschon, D.E., Miranda, E., Ordonez, A., Hannan, N.R., Rouhani, F.J., et al. (2011). Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391-394. DOI ScienceOn
19	Zhu, X., Xu, Y., Yu, S., Lu, L., Ding, M., Cheng, J., Song, G., Gao, X., Yao, L., Fan, D., et al. (2014). An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 system. Sci. Rep. 4, 6420. DOI ScienceOn
20	Ran, F.A., Cong, L., Yan, W.X., Scott, D.A., Gootenberg, J.S., Kriz, A.J., Zetsche, B., Shalem, O., Wu, X., Makarova, K.S., et al. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186-191. DOI ScienceOn
21	Smith, C., Gore, A., Yan, W., Abalde-Atristain, L., Li, Z., He, C., Wang, Y., Brodsky, R.A., Zhang, K., Cheng, L., et al. (2014). Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell 15, 12-13. DOI ScienceOn
22	Tebas, P., Stein, D., Tang, W.W., Frank, I., Wang, S.Q., Lee, G., Spratt, S.K., Surosky, R.T., Giedlin, M.A., Nichol, G., et al. (2014). Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl. J. Med. 370, 901-910. DOI ScienceOn
23	Tsai, S.Q., Zheng, Z., Nguyen, N.T., Liebers, M., Topkar, V.V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A.J., Le, L.P., et al. (2015). GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187-197. DOI
24	Urnov, F.D., Miller, J.C., Lee, Y.L., Beausejour, C.M., Rock, J.M., Augustus, S., Jamieson, A.C., Porteus, M.H., Gregory, P.D., and Holmes, M.C. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646-651. DOI ScienceOn
25	Veres, A., Gosis, B.S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C.A., Talkowski, M.E., and Musunuru, K. (2014). Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell 15, 27-30. DOI ScienceOn
26	Vouillot, L., Thelie, A., and Pollet, N. (2015). Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases. G3 (Bethesda) 5, 407-415. DOI ScienceOn
27	Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., and Bonas, U. (2009). Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326, 1509-1512. DOI ScienceOn
28	Bae, S., Park, J., and Kim, J.S. (2014). Cas-OFFinder: A fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473-1475. DOI ScienceOn
29	Bibikova, M., Beumer, K., Trautman, J.K., and Carroll, D. (2003). Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764. DOI ScienceOn
30	Bitinaite, J., Wah, D.A., Aggarwal, A.K., and Schildkraut, I. (1998).FokI dimerization is required for DNA cleavage. Proc. Natl. Acad. Sci. USA 95, 10570-10575. DOI
31	Brunet, E., Simsek, D., Tomishima, M., DeKelver, R., Choi, V.M., Gregory, P., Urnov, F., Weinstock, D.M., and Jasin, M. (2009). Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl. Acad. Sci. USA 106, 10620-10625. DOI ScienceOn
32	Cho, S.W., Kim, S., Kim, J.M., and Kim, J.S. (2013a). Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230-232. DOI ScienceOn
33	Cradick, T.J., Fine, E.J., Antico, C.J., and Bao, G. (2013) CRISPR/as9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41, 9584-9592. DOI ScienceOn
34	Cho, S.W., Lee, J., Carroll, D., Kim, J.S., and Lee, J. (2013b). Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics 195, 1177-1180. DOI ScienceOn
35	Cho, S.W., Kim, S., Kim, Y., Kweon, J., Kim, H.S., Bae, S., and Kim, J.S. (2014). Analysis of off-target effects of CRISPR/Casderived RNA-guided endonucleases and nickases. Genome Res. 24, 132-141. DOI ScienceOn
36	Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823. DOI
37	Crosetto, N., Mitra, A., Silva, M.J., Bienko, M., Dojer, N., Wang, Q., Karaca, E., Chiarle, R., Skrzypczak, M., Ginalski, K., et al. (2013). Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 10, 361-365. DOI ScienceOn
38	Frock, R.L., Hu, J., Meyers, R.M., Ho, Y.J., Kii, E., and Alt, F.W. (2015). Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33, 179-186. DOI
39	Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K., and Sander, J.D. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822-826. DOI ScienceOn
40	Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M., and Joung, J.K. (2014). Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279-284. DOI ScienceOn
41	Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821. DOI ScienceOn
42	Gabriel, R., Lombardo, A., Arens, A., Miller, J.C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C.C., Wang, J., Friedman, G., et al. (2011). An unbiased genome-wide analysis of zincfinger nuclease specificity. Nat. Biotechnol. 29, 816-823. DOI ScienceOn
43	Hendel, A., Kildebeck, E.J., Fine, E.J., Clark, J.T., Punjya, N., Sebastiano, V., Bao, G., and Porteus, M.H. (2014). Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing. Cell Rep. 7, 293-305. DOI ScienceOn
44	Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827-832. DOI ScienceOn
45	Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., and Doudna, J. (2013). RNA-programmed genome editing in human cells. Elife 2, e00471.
46	Kim, H., and Kim, J.S. (2014). A guide to genome engineering with programmable nucleases. Nat. Rev. Genet. 15, 321-334. DOI ScienceOn
47	Kim, Y.G., Cha, J., and Chandrasegaran, S. (1996). Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl. Acad. Sci. USA 93, 1156-1160. DOI
48	Kim, H.J., Lee, H.J., Kim, H., Cho, S.W., and Kim, J.S. (2009). Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res. 19, 1279-1288. DOI ScienceOn
49	Kim, H., Um, E., Cho, S.R., Jung, C., and Kim, J.S. (2011). Surrogate reporters for enrichment of cells with nucleaseinduced mutations. Nat. Methods 8, 941-943. DOI ScienceOn
50	Kim, J.S., Lee, H.J., and Carroll, D. (2010). Genome editing with modularly assembled zinc-finger nucleases. Nat. Methods 7, 91; author reply 91-92.
51	Kim, E., Kim, S., Kim, D.H., Choi, B.S., Choi, I.Y., and Kim, J.S. (2012). Precision genome engineering with programmable DNA-nicking enzymes. Genome Res. 22, 1327-1333. DOI ScienceOn
52	Kim, Y., Kweon, J., Kim, A., Chon, J.K., Yoo, J.Y., Kim, H.J., Kim, S., Lee, C., Jeong, E., Chung, E., et al. (2013a). A library of TAL effector nucleases spanning the human genome. Nat. Biotechnol. 31, 251-258. DOI ScienceOn
53	Kim, Y., Kweon, J., and Kim, J.S. (2013b). TALENs and ZFNs are associated with different mutation signatures. Nat. Methods 10, 185. DOI ScienceOn
54	Kim, Y.K., Wee, G., Park, J., Kim, J., Baek, D., Kim, J.S., and Kim, V.N. (2013c). TALEN-based knockout library for human microRNAs. Nat. Struct. Mol. Biol. 20, 1458-1464. DOI ScienceOn
55	Kim, J.M., Kim, D., Kim, S., and Kim, J.S. (2014a). Genotyping with CRISPR-Cas-derived RNA-guided endonucleases. Nat. Commun. 5, 3157.
56	Kim, S., Kim, D., Cho, S.W., Kim, J., and Kim, J.S. (2014b). Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012- 1019. DOI ScienceOn
57	Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H.R., Hwang, J., Kim, J.I. and Kim, J.S. (2015). Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods 12, 237-243. DOI ScienceOn

Reference

5	Srinivasan Chandrasegaran. (2016) Journal of Molecular Biology Origins of Programmable Nucleases for Genome Engineering / 428 (5) , 963
9	Jin-Soo Kim. (2016) Nature Protocols Genome editing comes of age / 11 (9) , 1573
2	Lang Yi. (2016) Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges / 1866 (2) , 197
2	Han Zhang. (2016) British Journal of Haematology CRISPR-Cas9 technology and its application in haematological disorders / 175 (2) , 208
2	Daniel Brown. (2016) Journal of Cardiovascular Development and Disease Advances in the Study of Heart Development and Disease Using Zebrafish / 3 (2) , 13
3	Lindsey A Lonowski. (2017) Nature Protocols Genome editing using FACS enrichment of nuclease-expressing cells and indel detection by amplicon analysis / 12 (3) , 581
7	Diana Resetca. (2016) Journal of Immunotherapy Engineering Hematopoietic Cells for Cancer Immunotherapy / 39 (7) , 249
2	Chul-Yong Park. (2015) Cell Stem Cell Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9 / 17 (2) , 213
3	Dana Carroll. (2016) Molecular Therapy A Perspective on the State of Genome Editing / 24 (3) , 412
1	Lisa Lombardi. (2017) Scientific Reports Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9 / 7 (1)
3	Jaichandran Sivalingam. (2016) Molecular Therapy Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells / 24 (3) , 607
10	Kentaro Ishida. (2015) International Journal of Molecular Sciences Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases / 16 (10) , 24751
2	Hui-Ying Xue. (2016) Journal of Medical Genetics CRISPR-Cas9 for medical genetic screens: applications and future perspectives / 53 (2) , 91
2	S. V. Gerasimova. (2017) Russian Journal of Plant Physiology Genome editing system CRISPR/CAS9 and peculiarities of its application in monocots / 64 (2) , 141
7	Chidananda Nagamangala Kanchiswamy. (2016) Plant Cell Reports DNA-free genome editing methods for targeted crop improvement / 35 (7) , 1469
3	Maximilian Müller. (2016) Molecular Therapy Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome / 24 (3) , 636
2	Suzy Markossian. (2016) Journal of Molecular Endocrinology CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists / 57 (2) , R81
	Mickael Malnoy. (2016) Frontiers in Plant Science DNA-Free Genetically Edited Grapevine and Apple Protoplast Using CRISPR/Cas9 Ribonucleoproteins / 7
	Venera S. Kamburova. (2017) International Journal of Agronomy Genome Editing in Plants: An Overview of Tools and Applications / 2017 , 1
1	Dana Carroll. (2015) Genome Biology The societal opportunities and challenges of genome editing / 16 (1)
	Manjunath N. Swamy. (2016) Advanced Drug Delivery Reviews Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS / 103 , 174
1	Daniel B. Graham. (2015) Genome Biology Resources for the design of CRISPR gene editing experiments / 16 (1)
10	Ayman Eid. (2016) Experimental & Molecular Medicine Genome editing: the road of CRISPR/Cas9 from bench to clinic / 48 (10) , e265
	Hongmei Lisa Li. (2016) Methods Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system / 101 , 27
	Henriette O’Geen. (2015) Current Opinion in Chemical Biology How specific is CRISPR/Cas9 really? / 29 , 72
12	E. Sacide Çağlayan. (2016) Cell Biology International Generation of improved human cerebral organoids from single copyDYRK1Aknockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome / 40 (12) , 1256
2	Junwon Lee. (2016) Plant Biotechnology Journal Designed nucleases for targeted genome editing / 14 (2) , 448
13	S. Julia Wu. (2017) Cell Reports A Critical Analysis of the Role of SNARE Protein SEC22B in Antigen Cross-Presentation / 19 (13) , 2645
3	Josh Tycko. (2016) Molecular Cell Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity / 63 (3) , 355
11	Chul-Yong Park. (2016) Nature Protocols Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9 / 11 (11) , 2154
6	Kellie A Schaefer. (2017) Nature Methods Unexpected mutations after CRISPR–Cas9 editing in vivo / 14 (6) , 547
7	Chidananda Nagamangala Kanchiswamy. (2016) Trends in Biotechnology Fine-Tuning Next-Generation Genome Editing Tools / 34 (7) , 562
	Maxime Québatte. (2017) Current Opinion in Microbiology Systems-level interference strategies to decipher host factors involved in bacterial pathogen interaction: from RNAi to CRISPRi / 39 , 34
1	Taeyoung Koo. (2017) Briefings in Functional Genomics Therapeutic applications of CRISPR RNA-guided genome editing / 16 (1) , 38
2	Koen J. T. Venken. (2016) Wiley Interdisciplinary Reviews: Developmental Biology Genome engineering:Drosophila melanogasterand beyond / 5 (2) , 233
	Han B. Lee. (2016) Frontiers in Genetics Genome Engineering with TALE and CRISPR Systems in Neuroscience / 7
	Alison Louise Van Eenennaam. (2017) Current Opinion in Biotechnology Genetic modification of food animals / 44 , 27
9	Hong Jo Lee. (2015) Molecules and Cells Germline Modification and Engineering in Avian Species / 38 (9) , 743
	Bing Shui. (2016) Stem Cells International The Rise of CRISPR/Cas for Genome Editing in Stem Cells / 2016 , 1
4	Naglaa A Abdallah. (2015) GM Crops & Food Genome editing for crop improvement: Challenges and opportunities / 6 (4) , 183
4	Robert Sertori. (2016) Briefings in Functional Genomics Genome editing in zebrafish: a practical overview / 15 (4) , 322
11	(2018) PLOS ONE A study on endonuclease BspD6I and its stimulus-responsive switching by modified oligonucleotides / 13 (11) , e0207302
11	(2018) PLOS ONE Agnostic detection of genomic alterations by holistic DNA structural interrogation / 13 (11) , e0208054
00063592	(2018) Biotechnology and Bioengineering / (00063592)
1664-3224	(2018) Frontiers in Immunology Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9 / 9 (1664-3224)
12	(2017) International Journal of Molecular Sciences Applications of Alternative Nucleases in the Age of CRISPR/Cas9 / 18 (12) , 2565
12	(2017) STEM CELLS Translational Medicine Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases / 6 (12) , 2062
1	(2018) BMC Molecular Biology A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone / 19 (1)
1	(2018) Microbial Cell Factories CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus / 17 (1)
1	(2018) Stem Cell Research & Therapy Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model / 9 (1)
4	(2018) Moscow University Biological Sciences Bulletin Methods of Gene Therapy for Treatment of Inherited Epidermolysis Bullosa / 73 (4) , 191
10	(2018) Molecules and cells Editing of Genomic TNFSF9 by CRISPR-Cas9 Can Be Followed by Re-Editing of Its Transcript / 41 (10) , 917
2090-3162	(2018) Genetics Research International CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering / 2018 (2090-3162) , 1
1546-1696	(2018) Nature Biotechnology Unexpected CRISPR on-target effects / (1546-1696)
7	(2018) Expert Opinion on Orphan Drugs Advances in understanding disease mechanisms and potential treatments for Crigler–Najjar syndrome / 6 (7) , 425
8	(2018) Retina CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING / 38 (8) , 1443
2	(2018) Diseases Zebrafish Models of Rare Hereditary Pediatric Diseases / 6 (2) , 43
1	(2019) Microbial Cell Factories A rapid and versatile tool for genomic engineering in Lactococcus lactis / 18 (1)
None	(2017) F1000Research <I>In vivo</I> genome editing in animals using AAV-CRISPR system: applications to translational research of human disease / 6 (None) , 2153
1	(2018) Cogent biology Using pgRNA-Cas9 system to knockout MKL1 inhibited cell migration and proliferation / 4 (1) , 1426255
4	(2015) International journal of medical sciences While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action / 15 (4) , 309
None	(2015) Molecular and cellular probes Generation of conditional <I>Acvrl1</I> knockout mice by CRISPR/Cas9-mediated gene targeting / 37 (None) , 32
1	(2015) The CRISPR journal Applications of CRISPR-Cas9 Technology in Translational Research on Solid-Tumor Cancers / 1 (1) , 47
12	(2018) Genome research DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA / 28 (12) , 1894
34	(2015) Current medicinal chemistry Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance / 26 (34) , 6282
None	(2015) Frontiers in plant science Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants / 10 (None) , 550
16	(2015) RSC advances Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system / 9 (16) , 9067
16	(2015) RSC advances Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system / 9 (16) , 9067
None	(2015) Computational and structural biotechnology journal The Progress of CRISPR/Cas9-Mediated Gene Editing in Generating Mouse/Zebrafish Models of Human Skeletal Diseases / 17 (None) , 954
5	(2015) Nature microbiology Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9 / 4 (5) , 888
5	(2015) Journal of medical genetics Biallelic mutations in <I>USP45,</I> encoding a deubiquitinating enzyme, are associated with Leber congenital amaurosis / 56 (5) , 325
6	(2019) Human genetics Therapeutic application of the CRISPR system: current issues and new prospects / 138 (6) , 563
None	(2015) Molecular therapy. Nucleic acids Efficient Gene Editing at Major CFTR Mutation Loci / 16 (None) , 73
None	(2015) Molecular therapy. Nucleic acids Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application / 16 (None) , 326
7	(2015) The journal of gene medicine Delivery of CRISPR/Cas9 for therapeutic genome editing / 21 (7) , e3107
11	(2015) Experimental & molecular medicine : EMM Recent advances in the CRISPR genome editing tool set / 51 (11) , 1
r2	(2015) Human molecular genetics Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects / 28 (r2) , R254
4	(2019) Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease / 14 (4) , 595
1	(2019) Nature communications High-resolution specificity profiling and off-target prediction for site-specific DNA recombinases / 10 (1) , 1937
2	(2015) International journal of molecular sciences CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells / 21 (2) , 653
None	(2015) PeerJ Genome-wide Cas9 binding specificity in <I>Saccharomyces cerevisiae</I> / 8 (None) , e9442
None	(2020) Frontiers in cellular and infection microbiology CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics / 10 (None) , 576875
1	(2015) Briefings in functional genomics CRISPR/Cas9 for development of disease resistance in plants: recent progress, limitations and future prospects / 19 (1) , 26
2	(2020) New genetics and society Genome editing: the dynamics of continuity, convergence, and change in the engineering of life / 39 (2) , 219
None	(2015) Pharmacology & therapeutics Recent advances in genome editing of stem cells for drug discovery and therapeutic application / 209 (None) , 107501
5	(2020) Acta pharmacologica Sinica CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment / 41 (5) , 583
3	(2015) Current gene therapy Dissecting the Therapeutic Relevance of Gene Therapy in NeuroAIDS: An Evolving Epidemic / 20 (3) , 174
9	(2015) Parasite immunology CRISPR/Cas9 gene drive technology to control transmission of vector‐borne parasitic infections / 42 (9) , e12762
9	(2015) Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine A novel <I>GNAS</I>-mutated human induced pluripotent stem cell model for understanding <I>GNAS</I>-mutated tumors / 42 (9) , 101042832096258
7	(2020) The journal of immunology : official journal of the American Association of Immunologists CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice / 205 (7) , 1763
None	(2020) Scientific reports TALEN mediated gene editing in a mouse model of Fanconi anemia / 10 (None) , 6997
1	(2015) Genome biology Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides / 21 (1) , 51
None	(2015) Frontiers in genome editing Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope? / 2 (None) , 615619
2	(2021) Nature protocols Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq / 16 (2) , 1170
7	(2021) Agronomy Applications and Potential of Genome-Editing Systems in Rice Improvement: Current and Future Perspectives / 11 (7) , 1359
None	(2021) Neuropharmacology Genetic manipulations of AMPA glutamate receptors in hippocampal synaptic plasticity / 194 (None) , 108630
None	(2015) Journal of immunology and regenerative medicine Advances in generating HLA-Universal platelets for transfusion medicine / 14 (None) , 100053